Clinical Research Tricuspid Annuloplasty for Tricuspid Regurgitation Secondary to Left-Sided Heart Valve Disease: Immediate Outcomes and Risk Factors for Late Failure
2016
Background: Tricuspid valve annuloplasty is the treatment of choice for tricuspid regurgitation (TR) secondary to left-sided heart valve disease (functional TR). Methods: Between 1999 and 2014, 527 consecutive patients (mean age, 69.6 � 9.5 years) with grade � 1þ functional TR (graded from 03þ) underwent tricuspid annuloplasty in addition to left-sided heart valve operations at the authors’ institution. The operative risk (by the European System for Cardiac Operative Risk Evaluation II [EuroSCORE II]) was 10.4% � 12.2%. Clinical data and echocardiographic studies were reviewed retrospectively during a mean follow-up of 5.2 � 3.5 years. Risk factors for late repair failure were identified by multivariable analysis. Results: Either suture (De Vega) or device annuloplasty was used in 14.8% and 85.2% of patients, respectively. Concomitant mitral or aortic valve surgery was performed in 92.6% and 35.9% of cases, respectively. There were 48 (9.1%) hospital deaths. The 10-year nonparametric estimates of freedom from all-cause death, cardiac RESUME
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
24
References
0
Citations
NaN
KQI